Objectives We investigated disparities in suicide attempt risk among Black/African American, Hispanic/Latinx, and White female youth in New York City (NYC) compared to National trends in the United States (US).

Methods This study used data from the CDC Youth Risk Behavior Survey (YRBS) from 1997-2023. We analyzed self-reported racial/ethnic category, biological sex, and suicide attempt status. Suicide attempt risk and risk ratios were determined using logistic regression.

Survey Population Our sample included 83,347 female youth Nationally (age in years M = 15.98, SD = 1.22) and 29,802 in NYC (age in years M = 15.56, SD = 1.24), with 9,480 (National) and 3,864 (NYC) of these females having attempted suicide at least once.

Results Both samples showed the highest increases in suicide attempt risk among Black/African American female youth. While National and NYC samples showed significant racial disparities, these disparities were higher in NYC, especially during the COVID-19 pandemic.

Conclusions This study showed pervasive racial disparities in suicide attempt risk for female youth and is one of the first to directly analyze local-level risk in female youth from a majority Black/African American and Hispanic/Latina sample.

The authors have declared no competing interest.

No funding external to the NYU McSilver Institute was received for this work.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We used publicly available data from the CDC, and in accordance with the Common Rule, Institutional Review Board (IRB) approval and informed consent were not necessary.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes